Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

This funding opportunity from the FDA seeks proposals for developing physiologically based pharmacokinetic (PBPK) model-based mechanistic in vitro-in vivo correlations (IVIVCs) for long-acting injectable suspensions and implants. The project is a U01 grant with an optional clinical trial component.